A newly formed Ottawa-based medical cannabis company says it’s purchased the assets of another local pot firm as it builds out an R&D operation and explores genetic engineering methods to produce pharmaceutical-grade marijuana.
Fairway Green Cannabis was launched earlier this month and is headed by Michael Inskip, a former high-tech sales and marketing executive who later led a capital pool company, Thoroughbred Capital. Fairway Green Cannabis says it plans to cultivate cannabis for medical and pharmaceutical applications as well as invest heavily in R&D, including “alternative growing strategies,” engineered enzymes and tailored genetics.
The company’s leadership team also includes local intellectual property lawyer Gordon Freedman.
OBJ360 (Sponsored)
Care, Serve, & Give: Dr. Helen Tang is redefining what it means to lead with purpose
Dr. Helen Tang is a dynamic and multifaceted leader whose passion for community and philanthropy is at the heart of everything she does. As a devoted mother of two and
Matching donations matters: How local companies help enable life-saving care for children in need
Self-storage company Access Storage is proud to support healthy communities where its employees work and live – and in the case of Ottawa, that means joining a host of other
This week, Fairway Green Cannabis said it was acquiring the assets of NordikLeaf, a local cannabis company led by Ottawa entrepreneur James MacKenzie. NordikLeaf secured a 25-acre property outside Perth in 2019 that it intended to convert to cannabis cultivation.
Terms of the transaction were not disclosed.
Fairway Green Cannabis says it’s in the process of obtaining a cannabis production licence from Health Canada.
